Source: BioPortfolio

SPH: Shanghai Pharma Global Standard Stock Incentive Scheme to Push Innovation Refiled for Approval

New stock incentive plan to place Shanghai Pharma on par with worldleading pharmaceutical innovators SHANGHAI Oct. 1 2019 PRNewswire Shanghai Pharmaceuticals Holding Co. Ltd. Shanghai Pharma Hong Kong Stock Exchange 2607...

Read full article »
Annual Revenue
$10-50B
Employees
10-50K
Cho Man's photo - President & CEO of Shanghai Pharmaceuticals Holding Co. Ltd.

President & CEO

Cho Man

CEO Approval Rating

70/100

Read more